Mayo Clinic's Department of Radiation Oncology has launched the PSA Control Tower, an innovative tool designed to enhance the ...

It’s a problem with not nearly enough attention. Prostate cancer hits men hard all over the world—it’s one of the biggest ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Probiotics and broccoli could help to slow the spread of prostate cancer, research suggests. Broccoli, turmeric, pomegranate, ...

Treatment with Leuprorelin did not improve OS or disease-specific survival for patients with nonmetastatic, high-risk prostate cancer who have undetectable PSA levels, while causing more adverse ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...